Dry Eye Disease Market 2019-2025
07-Jan-2019 | Number of pages: 190 | Report Id: BMRC HC 109 | Report Format: | Status: Published

Dry Eye Disease Market By Product Type (Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogue), By Distribution Channel (Hospital Pharmacies, Hospital Pharmacies, Online Pharmacies), Industry Analysis, Trends, and Forecast 2019 – 2025

Dry Eye Disease Market is valued around USD 2796.8 Million in 2018 and expected to reach USD 3778.1 Million by 2025 with the CAGR of 4.7% over the forecast period. Increase in geriatric population and various environmental factors are the key drivers for Global Dry Eye Disease Market.

Dry eye disease market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about dry eye disease market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with product type, distribution channel.

Dry eye disease is caused due to the lack of tears or lubrication in eyes which led to the burning sensation and redness in eyes. These tears provide lubrication and each blink spread tears evenly and provide nourishment to the eyes. When the production and drainage of tears are not balanced then it leads to the dry eye disease. This condition is most commonly occurs in older population and there are various environmental conditions which are responsible for such condition in young adults as well. The few symptoms experienced by the people suffering from dry eye disease are irritation, burning sensation, blurred vision and advanced stage may also lead to the vision impairment.

There are various factors driving the growth of the dry eye disease market, one of the major factors driving the growth of this market is increasing geriatric population. Due to the weakening of muscles and glands in geriatric people it is most common condition among them. As per Population Reference Bureau report, the number of Americans ages 65 and older is projected to more than double from 46 million today to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent.  Furthermore, there are various research and development activities carried by major players which led to the development of novel drugs and devices for the treatment of this condition. Moreover, there is a constant increase in population and various other environmental factors which may affect the tear production which led to the dry eye disease. However, stringent regulations and high cost of dry eye disease are expected inhibit the growth of dry eye disease market over the forecast period.

Global dry eye disease market report covers prominent players like Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Allergan plc, Shire plc, TRB Chemedica International SA, Mitotech S.A., Sun Pharmaceutical Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Valeant Pharmaceuticals International, Inc., Otsuka Pharmaceutical Co., Ltd., Novartis AG, FCI S.A.S. and others.

Dry Eye Disease Market Segmentation –

By Product Type 

  • Artificial Tears
  • Anti-inflammatory Drugs
  • Punctal Plugs
  • Secretagogue

By Distribution Channel 

  • Hospital Pharmacies
  • Independent Pharmacies and Drug Stores
  • Online Pharmacies

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Dry Eye Disease Market key Players

Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Allergan plc
Shire plc
TRB Chemedica International SA
Mitotech S.A.
Sun Pharmaceutical Industries Ltd.
Senju Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.

 

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Dry Eye Disease Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Dry Eye Disease Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Dry Eye Disease Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Dry Eye Disease Market Overview: Quantitative Analysis
    • Global Dry Eye Disease Market Consumption, Market Share ( %) and Growth Rate, 2015- 2025
    • Global Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015- 2025
  2. Chapter – Global Dry Eye Disease Market Analysis: by Product Type
  3. Chapter – Global Dry Eye Disease Market Analysis: by Distribution Channel
  4. Chapter – Global Dry Eye Disease Market Analysis: by Manufacturer
    • Global Dry Eye Disease Market Revenue (USD Million), by Manufacturer, 2015 – 2018
    • Global Dry Eye Disease Market Consumption, Manufacturer, 2015 – 2018
    • Global Dry Eye Disease Market Share (%), by Manufacturer, 2018
    • Global Dry Eye Disease Market Price (USD/Unit), by Manufacturer, 2015 – 2018
    • Global Dry Eye Disease Market Revenue Growth Rate (%), by Manufacturer, 2015 – 2018
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  5. Chapter – Dry Eye Disease Market: Regional Analysis
    • North America
      • North America Dry Eye Disease Market Revenue (USD Million) and Growth Rate (%), 2015 – 2025.
      • North America Dry Eye Disease Market Revenue (USD Million) By Country, 2015 – 2025.
      • North America Dry Eye Disease Revenue Market Share (%) By Country, 2015 – 2025.
      • North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
      • North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
      • North America Dry Eye Disease Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015 – 2025.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  6. Chapter – Company Profiles
    • Santen Pharmaceutical Co., Ltd.
      • Overview
      • Financials
      • Product portfolio
      • Dry Eye Disease Market Revenue (USD Million), Consumption  and Market Share (%), 2015 – 2018
      • Dry Eye Disease Sales Market Share (%), 2015 – 2018
      • Business strategy
      • Recent developments
    • Johnson & Johnson
    • Allergan plc
    • Shire plc
    • TRB Chemedica International SA
    • Mitotech S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Senju Pharmaceutical Co., Ltd.
    • Sentiss Pharma Pvt. Ltd.
    • Valeant Pharmaceuticals International, Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • Novartis AG
    • FCI S.A.S.
    • Others
  7. Chapter – Market Research and Findings

Santen Pharmaceutical Co., Ltd.
Johnson & Johnson
Allergan plc
Shire plc
TRB Chemedica International SA
Mitotech S.A.
Sun Pharmaceutical Industries Ltd.
Senju Pharmaceutical Co., Ltd.
Sentiss Pharma Pvt. Ltd.
Valeant Pharmaceuticals International, Inc.
Otsuka Pharmaceutical Co., Ltd.
Novartis AG
FCI S.A.S.
Others